Stefanos Theoharis
Company: OneChain Immunotherapeutics
Job title: Chief Executive Officer
Seminars:
Panel Discussion: Allogeneic vs Autologous vs In Vivo: How will these Co-Exist? 11:30 am
Comparing advantages and limitations of each approach to determine optimal applications Discussing key challenges faced by each approach to enlighten considerations in development Unearthing novel methods to advance efficacies in both approaches Read more
day: Cell Therapy Fundamentals Day